ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week
NCT ID: NCT00544180
Last Updated: 2009-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
7 participants
INTERVENTIONAL
2005-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risedronate Sodium in Post Menopausal Osteoporosis
NCT00453492
Satisfaction and Compliance of Risedronate in PMO
NCT00549965
A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis
NCT00632216
A Study of Monthly Risedronate for Osteoporosis
NCT00247273
Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women
NCT00353080
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Risedronate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Established osteoporosis
Exclusion Criteria
* Diagnosis of hypocalcemia, hyperparathyroidism, hyperthyroidism
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
55 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Procter and Gamble
INDUSTRY
Sanofi
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
sanofi-aventis
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Marc Chantelot, MD
Role: STUDY_DIRECTOR
Sanofi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sanofi-Aventis
Netanya, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RISED_L_01686
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.